Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

QUOC V TRUONG

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1518922814
CMS profile
250830
Location
WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$91,461.09

398 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $18,973.56 32
Incyte Corporation $13,525.80 15
Epizyme, Inc., $10,683.09 13
JAZZ PHARMACEUTICALS INC. $10,239.33 6
Eisai Inc. $9,490.71 13
BeiGene USA, Inc. $6,271.77 11
E.R. Squibb & Sons, L.L.C. $4,396.05 32
Janssen Biotech, Inc. $4,231.93 13
Pharmacyclics LLC, An AbbVie Company $4,197.41 11
AbbVie Inc. $1,732.77 8
Daiichi Sankyo Inc. $1,581.40 16
Novartis Pharmaceuticals Corporation $1,038.67 41
Karyopharm Therapeutics Inc. $775.06 2
Celgene Corporation $629.74 5
Verity Pharmaceuticals Inc. $500.00 1
PUMA BIOTECHNOLOGY, INC. $340.89 6
GENZYME CORPORATION $273.14 10
Amgen Inc. $270.40 18
Seagen Inc. $234.86 16
Lilly USA, LLC $234.59 9
Ipsen Biopharmaceuticals, Inc $162.90 3
Merck Sharp & Dohme Corporation $139.84 8
Bayer HealthCare Pharmaceuticals Inc. $125.58 9
Takeda Pharmaceuticals U.S.A., Inc. $124.19 12
Regeneron Healthcare Solutions, Inc. $115.93 7
Genentech USA, Inc. $112.17 11
GlaxoSmithKline, LLC. $110.80 10
PFIZER INC. $102.76 11
Deciphera Pharmaceuticals Inc. $91.56 1
Taiho Oncology, Inc. $74.36 4
Foundation Medicine, Inc. $49.24 2
EMD Serono, Inc. $48.80 3
Astellas Pharma US Inc $45.63 3
Acrotech Biopharma LLC $45.44 3
Kite Pharma, Inc. $44.14 3
Alexion Pharmaceuticals, Inc. $43.04 3
Blueprint Medicines Corporation $41.67 3
TerSera Therapeutics LLC $36.63 2
SUN PHARMACEUTICAL INDUSTRIES INC. $35.36 2
Rigel Pharmaceuticals, Inc. $34.24 2
Gilead Sciences, Inc. $28.69 2
Dendreon Pharmaceuticals LLC $27.10 1
Kyowa Kirin, Inc. $26.08 2
Janssen Pharmaceuticals, Inc $20.63 1
Blue Earth Diagnostics Limited $17.72 1
TOLMAR Pharmaceuticals, Inc. $16.91 1
Boehringer Ingelheim Pharmaceuticals, Inc. $16.73 1
Coherus Biosciences Inc. $15.42 1
Servier Pharmaceuticals LLC $14.83 1
Dova Pharmaceuticals $13.70 1
Exelixis Inc. $12.63 1
Myriad Genetic Laboratories, Inc. $12.54 1
Acceleron Pharma, Inc. $12.39 1
Heron Therapeutics, Inc. $10.22 1
ARRAY BIOPHARMA INC $10.05 2

Page 4 of 8; records 151–200 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

QUOC V TRUONG

NPI 1518922814 · CMS profile ID 250830

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 8; records 151–200 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1518922814?year=2021&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
QUOC V TRUONG, NPI 1518922814, CMS profile ID 250830. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1518922814?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). QUOC V TRUONG, NPI 1518922814, CMS profile ID 250830. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1518922814?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
QUOC V TRUONG, NPI 1518922814, CMS profile ID 250830, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 8; records 151–200 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1518922814?year=2021&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

398 matching records · $91,461.09 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 398 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 398.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $3.2408/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820309775 CMS
Amgen Inc. $12.0908/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825697151 CMS
E.R. Squibb & Sons, L.L.C. $1.9908/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783613203 CMS
PFIZER INC. $15.5308/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832672349 CMS
PFIZER INC. $10.2908/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833269345 CMS
Novartis Pharmaceuticals Corporation $8.4608/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813323983 CMS
Lilly USA, LLC $12.9408/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818689147 CMS
Novartis Pharmaceuticals Corporation $21.1608/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813323979 CMS
AstraZeneca Pharmaceuticals LP $107.5808/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830183593 CMS
GENZYME CORPORATION $24.7708/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843548543 CMS
E.R. Squibb & Sons, L.L.C. $1.5708/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783613199 CMS
E.R. Squibb & Sons, L.L.C. $5.0208/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783613201 CMS
AstraZeneca Pharmaceuticals LP $13.9807/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829409229 CMS
Eisai Inc. $750.0007/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833776265 CMS
Epizyme, Inc., $9.1407/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832343321 CMS
Incyte Corporation $4,920.0007/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835534707 CMS
Pharmacyclics LLC, An AbbVie Company $4.0907/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781015749 CMS
BeiGene USA, Inc. $21.1507/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846699133 CMS
E.R. Squibb & Sons, L.L.C. $11.1207/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783613211 CMS
Epizyme, Inc., $500.0007/29/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832343319 CMS
Amgen Inc. $19.1207/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826411915 CMS
Blueprint Medicines Corporation $13.2407/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848929341 CMS
Janssen Biotech, Inc. $14.4007/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788341897 CMS
Regeneron Healthcare Solutions, Inc. $9.9907/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809632255 CMS
Seagen Inc. $16.8507/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832145819 CMS
AbbVie Inc. $1,650.0007/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796175417 CMS
BeiGene USA, Inc. $125.0007/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846699139 CMS
BeiGene USA, Inc. $2,700.0007/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846699141 CMS
Lilly USA, LLC $17.7407/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818717599 CMS
Seagen Inc. $79.9507/15/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832145813 CMS
E.R. Squibb & Sons, L.L.C. $6.4507/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783613189 CMS
Eisai Inc. $121.3607/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833752653 CMS
Eisai Inc. $2,700.0007/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833777645 CMS
Takeda Pharmaceuticals U.S.A., Inc. $0.4907/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820309767 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.4207/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820309771 CMS
Daiichi Sankyo Inc. $20.0507/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836306061 CMS
PFIZER INC. $6.4507/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833268157 CMS
Blue Earth Diagnostics Limited $17.7207/01/2021 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 844638505 CMS
Incyte Corporation $4,920.0007/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835534665 CMS
E.R. Squibb & Sons, L.L.C. $2.7306/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783613175 CMS
GENZYME CORPORATION $124.9106/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843548523 CMS
Janssen Biotech, Inc. $11.6006/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788341899 CMS
Novartis Pharmaceuticals Corporation $5.6806/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813323975 CMS
Incyte Corporation $19.5806/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835534675 CMS
AstraZeneca Pharmaceuticals LP $16.4806/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829745567 CMS
E.R. Squibb & Sons, L.L.C. $3,655.0006/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783613205 CMS
PUMA BIOTECHNOLOGY, INC. $14.9106/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834088285 CMS
Bayer HealthCare Pharmaceuticals Inc. $11.9406/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789099120 CMS
Ipsen Biopharmaceuticals, Inc $27.4606/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841908393 CMS
Novartis Pharmaceuticals Corporation $14.8706/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813323967 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $144,944.70 409
PY2020 $57,439.67 260
PY2021 $91,461.09 398
PY2022 $81,504.84 335
PY2023 $43,483.03 299
PY2024 $62,915.48 298
PY2025 $56,806.99 266

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $180.00 1
PY2020 Principal investigator $140.00 3
PY2019 Principal investigator $341.50 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme Corporation $180.00 12/31/2021 Covered Recipient Teaching Hospital
VIA CHRISTI HOSPITAL WICHITA
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 848739195